מופירוסין אס.קיי.
k.s.kim international (sk- pharma) ltd., israel - mupirocin as calcium - mupirocin as calcium 20 mg/g - mupirocin
חומצה כנודאוקסיכולית לדיאנט
mbi pharma ltd., israel - chenodeoxycholic acid - קפסולה קשיחה - chenodeoxycholic acid 250 mg - chenodeoxycholic acid
איקון
gem pharma ltd - hyaluronic acid as sodium - טיפות עיניים - hyaluronic acid as sodium 0.15 mg/ml - hyaluronic acid - hyaluronic acid - symptomatic treatment of dry eye syndrome.
מוקסיפלוקסן אס.קיי.
k.s.kim international (sk- pharma) ltd., israel - moxifloxacin as hydrochloride - טיפות עיניים - moxifloxacin as hydrochloride 0.5 %w/v - moxifloxacin
טיקגרלור אינובמד 60 מג
inovamed pharma ltd, israel - ticagrelor - טבליות מצופות פילם - ticagrelor 60 mg - ticagrelor
טיקגרלור אינובמד 90 מג
inovamed pharma ltd, israel - ticagrelor - טבליות מצופות פילם - ticagrelor 90 mg - ticagrelor
ברפטובי 75 מג
medison pharma ltd - encorafenib - קפסולות ג'לטין קשיחות - encorafenib 75 mg - encorafenib
מקטובי 15מג
medison pharma ltd - binimetinib - טבליות מצופות פילם - binimetinib 15 mg - binimetinib
רוזובסטטין טבע ® 5 מ"ג
teva pharmaceutical indust.ltd - rosuvastatin as calcium 5 mg - tablets - rosuvastatin - primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate. homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate.
רוזובסטטין טבע ® 10 מ"ג
teva pharmaceutical indust.ltd - rosuvastatin as calcium 10 mg - tablets - rosuvastatin - primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate. homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate.